全文获取类型
收费全文 | 3477780篇 |
免费 | 283308篇 |
国内免费 | 14092篇 |
专业分类
耳鼻咽喉 | 48561篇 |
儿科学 | 111423篇 |
妇产科学 | 91011篇 |
基础医学 | 549361篇 |
口腔科学 | 94093篇 |
临床医学 | 308030篇 |
内科学 | 617425篇 |
皮肤病学 | 91665篇 |
神经病学 | 294704篇 |
特种医学 | 137470篇 |
外国民族医学 | 391篇 |
外科学 | 543007篇 |
综合类 | 102722篇 |
现状与发展 | 23篇 |
一般理论 | 2217篇 |
预防医学 | 289332篇 |
眼科学 | 79434篇 |
药学 | 240677篇 |
23篇 | |
中国医学 | 9839篇 |
肿瘤学 | 163772篇 |
出版年
2021年 | 55648篇 |
2020年 | 35395篇 |
2019年 | 58588篇 |
2018年 | 71933篇 |
2017年 | 54701篇 |
2016年 | 60410篇 |
2015年 | 74741篇 |
2014年 | 109178篇 |
2013年 | 174683篇 |
2012年 | 92202篇 |
2011年 | 92345篇 |
2010年 | 117384篇 |
2009年 | 121851篇 |
2008年 | 80207篇 |
2007年 | 83670篇 |
2006年 | 94412篇 |
2005年 | 90228篇 |
2004年 | 91761篇 |
2003年 | 83034篇 |
2002年 | 73427篇 |
2001年 | 104586篇 |
2000年 | 97336篇 |
1999年 | 97555篇 |
1998年 | 65456篇 |
1997年 | 63102篇 |
1996年 | 61068篇 |
1995年 | 56504篇 |
1994年 | 50762篇 |
1993年 | 47240篇 |
1992年 | 69697篇 |
1991年 | 66918篇 |
1990年 | 64319篇 |
1989年 | 63445篇 |
1988年 | 59422篇 |
1987年 | 57844篇 |
1986年 | 55199篇 |
1985年 | 55145篇 |
1984年 | 49744篇 |
1983年 | 45778篇 |
1982年 | 42225篇 |
1981年 | 39705篇 |
1980年 | 37398篇 |
1979年 | 41846篇 |
1978年 | 36494篇 |
1977年 | 33450篇 |
1976年 | 30800篇 |
1975年 | 30048篇 |
1974年 | 31266篇 |
1973年 | 30084篇 |
1972年 | 28351篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
M. RAUVALA K. AGLUND† U. PUISTOLA T. TURPEENNIEMI-HUJANEN‡ G. HORVATH§ R. WILLÉN & U. STENDAHL† 《International journal of gynecological cancer》2006,16(3):1297-1302
The incidence of uterine cervical cancer has increased slightly in Western countries, with an increase in relatively young women. Overexpression of matrix metalloproteinases (MMPs)-2 and -9 has turned out as a prognostic factor in many cancers. We compared the expression of the proteins MMP-2 and MMP-9 in cervical primary tumors with clinical outcome and risk factors of cervical cancer. One hundred sixty-one patients with cervical cancer treated in Ume? University Hospital or Sahlgrenska University Hospital, Sweden, between 1991 and 1995 were included in the study. Paraffin-embedded tissue samples obtained prior to treatment were examined immunohistochemically by specific antibodies for MMP-2 and MMP-9. Forty-two percent of the tumors were intensively positive for MMP-2 and 31% for MMP-9. Nineteen percent of the samples were intensively positive for both proteinases and 47% negative or weak for both. Overexpression of MMP-2 seemed to predict unfavorable survival under Kaplan-Meier analysis and in the multivariate analysis. Early sexual activity and low parity seemed to correlate to overexpression of MMP-2. MMP-9 was not associated with survival or sexual behavior. Intensive MMP-9 was noted in grade 1 tumors. We conclude that MMP-2 and MMP-9 have different roles in uterine cervical cancer. MMP-2 could be associated with aggressive behavior, but MMP-9 expression diminishes in high-grade tumors. 相似文献
992.
C. TASKIRAN K. YUCE P.O. GEYIK† T. KUCUKALI‡ & A. AYHAN 《International journal of gynecological cancer》2006,16(3):1342-1347
The purpose of this study was to predict lymphatic involvement in endometrial cancer using clinicopathologic variables of patients treated with surgical staging. Overall, 461 patients treated with an initial surgical staging procedure including complete pelvic-para-aortic lymphadenectomy were included. The mean number of resected lymph nodes was 27 (median 26; range 15-83), and 54 patients (12%) had lymphatic involvement. Of these patients, 32 had only pelvic, 15 had both pelvic and para-aortic, and 7 had isolated para-aortic metastases. In the multivariate analysis, deep myometrial invasion (P= 0.02), lymphvascular space invasion (P= 0.001), positive peritoneal cytology (P= 0.002), and cervical involvement (P= 0.003) predicted retroperitoneal lymph node metastasis (RLN) significantly. Two hundred seventy-four patients (59.4%) had at least one of these poor prognostic factors identified by multivariate analysis. In this patient population, 53 (19.3%) had lymphatic involvement compared to 1 patient in the group of 187 patients with low-risk criteria. Ninety-eight percent of patients with RLN were predicted by this model, and with the advent of accurate diagnostic techniques, 40% of patients could be saved from undergoing lymphadenectomy. 相似文献
993.
994.
995.
In a retrospective study using univariate analysis, we identified tumor type (nonendometrioid vs endometrioid), depth of myoinvasion (MI), mode of MI (infiltrative vs cohesive), and direct anatomic invasion of the cervical wall from the isthmus as significant positive risk factors for intramyometrial lymphvascular space involvement (LVSI). On multivariate analysis, tumor grade, depth of MI, and mode of MI retained their significance. We created a grid for the relative risks of LVSI with respect to these variables individually or in combination. We suggest that our indirect estimate of the risk of LVSI can help in assessing prognosis and determining the need for adjuvant therapy whenever LVSI is important in clinical decision making, but its pathologic diagnosis is uncertain. 相似文献
996.
997.
G. Kahlmeter D. F. J. Brown F. W. Goldstein A. P. MacGowan J. W. Mouton I. Odenholt A. Rodloff C-J. Soussy M. Steinbakk F. Soriano O. Stetsiouk 《Clinical microbiology and infection》2006,12(6):501-503
The main objectives of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) are to harmonise breakpoints for antimicrobial agents in Europe, and to act as the breakpoint committee for the European Medicines Agency (EMEA) during the registration of new antimicrobial agents. Detailed EUCAST procedures for harmonising and setting breakpoints for antimicrobial agents are available on the EUCAST website. Beginning with the current issue, a series of EUCAST Technical Notes will be published in CMI, based on the rationale documents produced by EUCAST for each of the antimicrobial agents studied, with the aim of highlighting important background information underlying decisions on breakpoints made by EUCAST. 相似文献
998.
999.
R. R. Reinert 《Clinical microbiology and infection》2006,12(9):942-943
1000.